Therini Bio
Therini Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 4 tracked investors.
About Therini Bio
Based in the United States, Therini Bio is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Therini Bio is a clinical-stage biotechnology company developing fibrin-targeting immunotherapies to block vascular-mediated inflammation and neuronal damage in neurological and retinal diseases. Its pipeline includes THN391, a candidate being tested in Phase 1b trials for diabetic macular edema and Alzheimer's disease.
Explore Therini Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.